Circulating secretoneurin concentrations in patients with moderate to severe aortic stenosis.
暂无分享,去创建一个
T. Edvardsen | M. Stridsberg | J. Brynildsen | G. Christensen | T. Omland | H. Røsjø | P. Myhre | L. Klaeboe | M. Lyngbakken
[1] C. Carlson,et al. Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca2+-Dependent Arrhythmia , 2019, Circulation. Arrhythmia and electrophysiology.
[2] V. Pettilä,et al. Circulating Secretoneurin Concentrations After Cardiac Surgery: Data From the FINNish Acute Kidney Injury Heart Study , 2019, Critical care medicine.
[3] Jeroen J. Bax,et al. Fourth universal definition of myocardial infarction (2018). , 2018, European heart journal.
[4] A. Bayés‐Genís,et al. Asymptomatic severe aortic stenosis: biomarkers are welcome , 2018, Heart.
[5] A. Pesenti,et al. Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study , 2018, Critical care medicine.
[6] V. Pettilä,et al. The predictive value of NT-proBNP and hs-TnT for risk of death in cardiac surgical patients. , 2018, Clinical biochemistry.
[7] Jeroen J. Bax,et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.
[8] B. Prendergast,et al. Serum biomarkers in valvular heart disease , 2017, Heart.
[9] Sheldon Goldberg,et al. Aortic Stenosis: Pathophysiology, Diagnosis, and Therapy. , 2017, The American journal of medicine.
[10] E. Ruokonen,et al. Prognostic Value of Secretoneurin in Critically Ill Patients With Infections , 2016, Critical care medicine.
[11] V. Pettilä,et al. Prognostic Value of Secretoneurin in Patients with Acute Respiratory Failure: Data from the FINNALI Study. , 2016, Clinical chemistry.
[12] A. Pasquet,et al. The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older , 2016, BMC Cardiovascular Disorders.
[13] C. Carlson,et al. Secretoneurin is a novel prognostic cardiovascular biomarker associated with cardiomyocyte calcium handling. , 2015, Journal of the American College of Cardiology.
[14] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[15] M. Dweck,et al. Left Ventricular Hypertrophy With Strain and Aortic Stenosis , 2014, Circulation.
[16] H. Ulmer,et al. Secretoneurin as a marker for hypoxic brain injury after cardiopulmonary resuscitation , 2014, Intensive Care Medicine.
[17] S. Walther,et al. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery. , 2014, British journal of anaesthesia.
[18] U. Wisløff,et al. Prognostic Value of Circulating MicroRNA-210 Levels in Patients with Moderate to Severe Aortic Stenosis , 2014, PloS one.
[19] K. Godang,et al. Effect of short- and long-term physical activities on circulating granin protein levels , 2013, Regulatory Peptides.
[20] I. Sjaastad,et al. Secretogranin II; a Protein Increased in the Myocardium and Circulation in Heart Failure with Cardioprotective Properties , 2012, PloS one.
[21] E. Ruokonen,et al. Prognostic value of chromogranin A in severe sepsis: data from the FINNSEPSIS study , 2012, Intensive Care Medicine.
[22] Wayne A. Decatur,et al. Is secretoneurin a new hormone? , 2012, General and comparative endocrinology.
[23] Y. Loh,et al. The extended granin family: structure, function, and biomedical implications. , 2011, Endocrine reviews.
[24] T. Edvardsen,et al. Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. , 2011, The American journal of cardiology.
[25] C. Carlson,et al. Chromogranin B in Heart FailureClinical Perspective , 2010 .
[26] C. Carlson,et al. Chromogranin B in Heart Failure: A Putative Cardiac Biomarker Expressed in the Failing Myocardium , 2010, Circulation. Heart failure.
[27] S. Aranki,et al. Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting. , 2008, The Journal of thoracic and cardiovascular surgery.
[28] M. Stridsberg,et al. Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours , 2008, Regulatory Peptides.
[29] A. Maisel,et al. State-of-the-Art PaperNatriuretic Peptides , 2007 .
[30] H. T. ter Keurs,et al. Calcium and arrhythmogenesis. , 2007, Physiological reviews.
[31] J. Gardin,et al. Burden of valvular heart diseases: a population-based study , 2006, The Lancet.
[32] P. Facer,et al. Secretoneurin: A new peptide in the human enteric nervous system , 1995, Histochemistry and Cell Biology.
[33] M. Brodmann,et al. Secretoneurin, an Angiogenic Neuropeptide, Induces Postnatal Vasculogenesis , 2004, Circulation.
[34] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.
[35] Douglas Losordo,et al. The Neuropeptide Secretoneurin Acts as a Direct Angiogenic Cytokine In Vitro and In Vivo , 2004, Circulation.
[36] A. Laslop,et al. Levels and molecular properties of secretoneurin-immunoreactivity in the serum and urine of control and neuroendocrine tumor patients. , 2000, The Journal of clinical endocrinology and metabolism.
[37] A. Laslop,et al. Secretogranin II: Molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin , 1995, Progress in Neurobiology.
[38] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .